Our innovative products and technologies are designed to meet current and future demands for medical radioisotopes. They mark a new era for nuclear medicine technology.
Medical radioisotopes are critical to meet patient healthcare needs and advance clinical research. We’ve charted the course for producing a stable, reliable and domestically sourced isotope supply.
Our people drive our solutions. From providing domestic supply of isotopes for patients to national security and environmental sustainability, we are committed to advancing radioisotope technology to shape a better world.
NOW FDA APPROVED!
NorthStar’s RadioGenix™ System is the first and only system of its kind. It is an innovative, high tech isotope separation platform indicated for use in producing the widely used and important medical radioisotope technetium-99m (Tc-99m) from NorthStar’s non-uranium produced molybdenum-99 (Mo-99).
INDICATION
RadioGenix™ System is a technetium Tc-99m generator used to produce sterile, non-pyrogenic Sodium Pertechnetate Tc 99m Injection. Sodium Pertechnetate Tc-99m Injection is indicated for use in the preparation of FDA approved diagnostic radiopharmaceuticals.
Sodium Pertechnetate Tc-99m Injection is also indicated in adults for Salivary Gland Imaging and Nasolacrimal Drainage System Imaging (dacryoscintigraphy), and in adults and pediatric patients for Thyroid Imaging and Urinary Bladder Imaging (direct isotopic cystography) for detection of vesicoureteral reflux.
IMPORTANT SAFETY INFORMATION
- Radiation Exposure Risk: Sodium Pertechnetate Tc-99m injection contributes to a patient’s long-term cumulative radiation exposure. Ensure safe handling to protect patients and health care workers from unintentional radiation exposure.
- Unintended Mo-99 Exposure: Only use potassium molybdate Mo-99, processing reagents, saline and other supplies, including kits, provided by NorthStar Medical Radioisotopes. Do not administer Sodium Pertechnetate Tc-99m Injection after the 0.15microCi of Mo-99/mCi of Tc-99m limit has been reached and discard the Sodium Pertechnetate Tc-99m Injection when the 12 hour expiration time is reached; whichever occurs earlier.
- Hypersensitivity Reactions: Monitor all patients for hypersensitivity reactions.
- Adverse Reactions: Allergic reactions, including anaphylaxis, have been reported infrequently following the administration of Sodium Pertechnetate Tc 99m Injection.
For more information, please call 1-844 GET-MOLY
© Copyright NorthStar Medical Technologies. All rights reserved. Terms & Conditions Privacy Policy Site Map